Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Recommendation of “Buy” from Analysts
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) has received an average rating of “Buy” from the five analysts that are covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) has received an average rating of “Buy” from the five analysts that are covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price […]
